In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

HeartFlow closes $240mm Series E

15 Feb 2018

Executive Summary

Cardiovascular device maker HeartFlow Inc. raised $240mm in its Series E financing from Wellington Management, Baillie Gifford, and returning shareholders. The company will use the funds for commercial expansion of its HeartFlow Analysis test that creates a computerized 3D model of the coronary arteries to assess heart disease. Additional funding will help with clinical trials and technology innovation.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • X-ray
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By